Los Angeles Capital Management’s Evolent Health EVH Stock Holding History

Los Angeles Capital Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$375K	Buy	+69,251	New	+$266K	﹤0.01%	988
2026 Q1	–	Sell	-492	Closed	-$3.25K	–	2466
2025 Q4	$3.25K	Buy	+492	New	+$2.73K	﹤0.01%	2367
2024 Q4	–	Sell	-15,191	Closed	-$430K	–	1157
2024 Q3	$430K	Buy	+15,191	New	+$392K	﹤0.01%	903
2023 Q3	–	Sell	-7,185	Closed	-$218K	–	1155
2023 Q2	$218K	Buy	7,185 +144	+2%	+$4.66K	﹤0.01%	1100
2023 Q1	$228K	Sell	7,041 -1,019	-13%	-$32.2K	﹤0.01%	1097
2022 Q4	$226K	Buy	+8,060	New	+$231K	﹤0.01%	1117
2021 Q2	–	Sell	-70,881	Closed	-$1.43M	–	1578
2021 Q1	$1.43M	Sell	70,881 -2,865	-4%	-$54.5K	0.01%	743
2020 Q4	$1.18M	Sell	73,746 -5,180	-7%	-$68.5K	0.01%	862
2020 Q3	$979K	Buy	78,926 +2,340	+3%	+$27.5K	﹤0.01%	825
2020 Q2	$545K	Buy	76,586 +28,736	+60%	+$192K	﹤0.01%	1082
2020 Q1	$260K	Buy	47,850 +35,290	+281%	+$315K	﹤0.01%	1099
2019 Q4	$114K	Buy	12,560 +220	+2%	+$1.79K	﹤0.01%	1234
2019 Q3	$89K	Buy	+12,340	New	+$88.6K	﹤0.01%	1242

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Los Angeles Capital Management's EVH Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Evolent Health (EVH) in Q2 2026: 69,251 shares worth $375K. The stake represents ﹤0.01% of the portfolio and ranks #988 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in EVH as recently as Q4 2025.

Los Angeles Capital Management first reported a position in EVH in Q3 2019 and has held it in 13 quarters since. The position peaked at $1.43M in Q1 2021. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Los Angeles Capital Management held 69,251 shares of Evolent Health worth $375K as of Q2 2026.
Evolent Health was a new Los Angeles Capital Management position in Q2 2026.
Evolent Health made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #988 holding.
Los Angeles Capital Management first reported a position in Evolent Health in Q3 2019 and has held it in 13 quarters since.
Los Angeles Capital Management's Evolent Health position peaked at $1.43M in Q1 2021.
198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.